At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 20 enrolled
Drug / intervention
Azelaic aciddrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Azelaic Acid (Financea Gel 15%) on Demodex Folliculorum Counts in Adult Subjects With Mild to Moderate Papulopustular Rosacea
In Brief
A Phase 3 clinical trial evaluating Azelaic acid for Rosacea. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to measure the effects of azelaic acid on Demodex folliculorum counts and disease condition via a split face design in approximately twenty patients with mild to moderate rosacea. The investigators hypothesize that treatment of rosacea with azelaic acid will lead to a decreased Demodex folliculorum count as well as an improvement in lesion count and redness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRosacea
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2010
Primary CompletionFeb 2012
First PostedJan 2017
TodayJul 2026
First PostedJan 30, 2017
Enrollment StartDec 1, 2010
Primary CompletionFeb 2, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.4 years ago
Interventions
Azelaic aciddrug
15% gel twice daily for four weeks to one side of face